BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9135033)

  • 1. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter.
    Emond P; Garreau L; Chalon S; Boazi M; Caillet M; Bricard J; Frangin Y; Mauclaire L; Besnard JC; Guilloteau D
    J Med Chem; 1997 Apr; 40(9):1366-72. PubMed ID: 9135033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.
    Garreau L; Emond P; Belzung C; Guilloteau D; Frangin Y; Besnard JC; Chalon S
    J Pharmacol Exp Ther; 1997 Jul; 282(1):467-74. PubMed ID: 9223589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.
    Neumeyer JL; Tamagnan G; Wang S; Gao Y; Milius RA; Kula NS; Baldessarini RJ
    J Med Chem; 1996 Jan; 39(2):543-8. PubMed ID: 8558525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
    Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
    Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs.
    Blough BE; Abraham P; Lewin AH; Kuhar MJ; Boja JW; Carroll FI
    J Med Chem; 1996 Sep; 39(20):4027-35. PubMed ID: 8831768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.
    Page G; Chalon S; Emond P; Maloteaux JM; Hermans E
    Neurochem Int; 2002 Feb; 40(2):105-13. PubMed ID: 11738476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new iodinated tropane derivative (beta-CDIT) for in vivo dopamine transporter exploration: comparison with beta-CIT.
    Emond P; Chalon S; Garreau L; Dognon AM; Bodard S; Frangin Y; Baulieu JL; Besnard JC; Guilloteau D
    Synapse; 1997 May; 26(1):72-80. PubMed ID: 9097407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter.
    Blough BE; Keverline KI; Nie Z; Navarro H; Kuhar MJ; Carroll FI
    J Med Chem; 2002 Aug; 45(18):4029-37. PubMed ID: 12190324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporter.
    Blough BE; Holmquist CR; Abraham P; Kuhar MJ; Carroll FI
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2445-7. PubMed ID: 11078197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments.
    Stepanov V; Schou M; Järv J; Halldin C
    Appl Radiat Isot; 2007 Mar; 65(3):293-300. PubMed ID: 17081763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel tropane analogues in comparison with the binding characteristics of [18F]FP-CIT and [131I]beta-CIT.
    Sihver W; Drewes B; Schulze A; Olsson RA; Coenen HH
    Nucl Med Biol; 2007 Feb; 34(2):211-9. PubMed ID: 17307129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.
    Chalon S; Garreau L; Emond P; Zimmer L; Vilar MP; Besnard JC; Guilloteau D
    J Pharmacol Exp Ther; 1999 Nov; 291(2):648-54. PubMed ID: 10525084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of tropane and nortropane analogues with phenyl substitutions as serotonin transporter ligands.
    Emond P; Helfenbein J; Chalon S; Garreau L; Vercouillie J; Frangin Y; Besnard JC; Guilloteau D
    Bioorg Med Chem; 2001 Jul; 9(7):1849-55. PubMed ID: 11425587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).
    Guilloteau D; Emond P; Baulieu JL; Garreau L; Frangin Y; Pourcelot L; Mauclaire L; Besnard JC; Chalon S
    Nucl Med Biol; 1998 May; 25(4):331-7. PubMed ID: 9639293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
    Chalon S; Hall H; Saba W; Garreau L; Dollé F; Halldin C; Emond P; Bottlaender M; Deloye JB; Helfenbein J; Madelmont JC; Bodard S; Mincheva Z; Besnard JC; Guilloteau D
    J Pharmacol Exp Ther; 2006 Apr; 317(1):147-52. PubMed ID: 16339913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.